Aptose shareholders approve reverse stock split and stock plan amendment; meeting adjourned for auditor search

Aptose Biosciences Inc.

All 7 director nominees re-elected with ≥97.69% votes for.
Shareholders approved amendment to 2021 stock plan increasing reserved shares by 458,126.
Reverse stock split authorized (1:2 to 1:20) at board discretion; ratio and date TBD.
Meeting adjourned to allow search for successor auditor to KPMG LLP; new meeting date to be set.

item 5.07item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.